Overview

A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Double blind, crossover randomized, multicentric study to compare efficacy and tolerability of concomitant administration of travoprost and brinzolamide versus timolol-dorzolamide fixed combination in patients with glaucoma or ocular hypertension
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Brinzolamide
Dorzolamide
Ophthalmic Solutions
Timolol
Travoprost